A Phase I Study of NK012 in Combination With Infusional 5-fluorouracil and Leucovorin in Patients With Advanced Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Colorectal Cancer.
Phase of Trial: Phase I
Latest Information Update: 19 Nov 2014
At a glance
- Drugs NK 012 (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Nippon Kayaku
- 12 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Mar 2013 Planned end date changed from 1 Dec 2011 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 19 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.